Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine

American Journal of Clinical Nutrition

Volumn 77, Issue 5, 2003, Pages 1296-1303

  Tran, Cuong D ^a   Howarth, Gordon S ^a,b,c   Coyle, Peter ^d   Philcox, Jeffrey C ^d   Rofe, Allan M ^d   Butler, Ross N ^a,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Intestinal permeability; Small intestine damage; Whey growth factor extract; Zinc

Indexed keywords

GROWTH FACTOR; METALLOTHIONEIN; METHOTREXATE; ZINC; ANTINEOPLASTIC ANTIMETABOLITE; GROWTH PROMOTOR; MILK PROTEIN; WHEY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEESE; CONTROLLED STUDY; COW; DIET SUPPLEMENTATION; DRUG EFFECT; HISTOPATHOLOGY; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MALE; MUCOSA INFLAMMATION; NONHUMAN; RAT; SCORING SYSTEM; WHEY; ANIMAL; CATTLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENTEROPATHY; HOSPITALIZATION; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PERMEABILITY; SPRAGUE DAWLEY RAT;

BOS TAURUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CATTLE; CHEESE; DIETARY SUPPLEMENTS; GROWTH SUBSTANCES; INTESTINAL DISEASES; INTESTINAL MUCOSA; MALE; METALLOTHIONEIN; METHOTREXATE; MILK PROTEINS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; ZINC;

EID: 0038135035     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.5.1296     Document Type: Article

References (40)

1. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 1997;92:385-9.
2. Sundstrom GM, Wahlin A, Nordin-Andersson I, Suhr OB. Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol 1998;61:250-4.
3. Rodriguez P, Darmon N, Chappuis P, et al. Intestinal paracellular permeability during malnutrition in guinea pigs: effects of high dietary zinc. Gut 1996;39:416-22.
4. Roy SK, Behrens RH, Haider R, et al. Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhea and persistent diarrhea syndrome. J Pediatr Gastroenterol Nutr 1992;15:289-96.
5. Alam AN, Sarker SA, Wahed MA, Khatun M, Rahaman MM. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 1994;35:1707-11.
6. Sazawal S, Black RE, Bhan MK, Bhandari N, Sinha A, Jalla S. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 1995;333:839-44.
7. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999;135:689-97.
8. McKenna KJ, Ligato S, Kauffman GL Jr, Abt AB, Stryker JA, Conter RL. Epidermal growth factor enhances intestinal mitotic activity and DNA content after acute abdominal radiation. Surgery 1994;115:626-32.
9. Sonis ST, Costa JW Jr, Evitts SM, Lindquist LE, Nicolson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992;74:749-55.
10. Fu X, Cuevas P, Gimenez-Gallego G, Wang Y, Sheng Z. The effects of fibroblast growth factors on ischemic kidney, liver and gut injuries. Chin Med J (Engl) 1998;111:398-403.
11. Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damage intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 1998;15:279-92.
12. Alavi K, Schwartz MZ, Palazzo JP, Prasad R. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J Pediatr Surg 2000;35:847-51.
13. Han DS, Li F, Holt L, et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver 2000;279:G1011-G22.
14. Cox DA, Burk RR. Isolation and characterization of milk growth factor, a transforming-growth-factor-beta 2-related polypeptide, from bovine milk. Eur J Biochem 1991;197:353-8.
15. Read LC, Upton FM, Francis GL, Wallace JC, Dahlenberg GW, Ballard FJ. Changes in the growth-promoting activity of human milk during lactation. Pediatr Res 1984;18:133-9.
16. Zumkeller W. Relationship between insulin-like growth factor-I and factor-II and IGF-binding proteins in milk and the gastrointestinal tract-growth and development of the gut. J Pediatric Gastroenterol Nutr 1992;15:357-69.
17. Francis GL, Regester GO, Webb HA, Ballard FJ. Enrichment of growth stimulating factors from cheese whey by cation-exchange chromatography. J Dairy Sci 1995;78:1209-18.
18. Rogers ML, Belford DA, Francis GL, Ballard FJ. Identification of fibroblast growth factors in bovine cheese whey. J Dairy Res 1995;62:501-7.
19. Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 1996;126:2519-30.
20. Porter SN, Howarth GS, Butler RN. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats. Scand J Gastroenterol 1998;33:967-74.
21. Belford DA, Rogers ML, Regester GO, et al. Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells. In Vitro Cell Dev Biol Anim 1995;31:752-60.
22. Taminiau JA, Gall DG, Hamilton JR. Response of the rat smallintestine epithelium to methotrexate. Gut 1980;21:486-92.
23. Eaton DL, Toal BF. Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol Appl Pharmacol 1982;66:134-42.
24. Davies NM, Wright MR, Jamali F. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharm Res 1994;11:1652-6.
25. Howarth GS, Xian CJ, Read LC. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors. 2000;18:119-33.
26. Ziegler TR, Estivariz CF, Jonas CR, Gu LH, Jones DP, Leader LM. Interactions between nutrients and peptide growth factors in intestinal growth, repair and function. J Parenter Enter Nutr 1999;23:S174-S83.
27. Read LC, Tomas FM, Howarth GS, et al. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol 1992;133:421-32.
28. Steeb CB, Trahair JF, Tomas FM, Read LC. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 1994;266(6 Pt 1):G1090-8.
29. Ninh NX, Thissen JP, Collette L, Gerard G, Khoi HH, Ketelslegers JM. Zinc supplementation increases growth and circulating insulin-like growth factor-I (IGF-I) in growth-retarded Vietnamese children. Am J Clin Nutr 1996;63:514-9.
30. DuBois RN, Bishop PR, Graves-Deal R, Coffey RJ. Transforming growth factor alpha regulation of two zinc finger-containing immediate early response genes in intestine. Cell Growth Differ 1995;6:523-9.
31. Dunbar AJ, Priebe IK, Sanderson MP, Goddard C. Purification and molecular characterization of recombinant rat betacellulin. J Mol Endocrinol 2001;27:239-47.
32. Egger B, Carey HV, Procaccino F, et al. Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut 1998;43:64-70.
33. Playford RJ, MacDonald CE, Calnan DP, et al. Co-administration of the health food supplement, bovine colostrum, reduces the acute nonsteroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) 2000;100:627-33.
34. Playford RJ, Floyd DN, Macdonald CE, et al. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 1999;44:653-8.
35. Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood) 2001;226:103-11.
36. 2+ in EGF protection of microtubules and intestinal barrier against oxidants. Am J Physiol Gastrointest Liver Physiol 2001;280:G828-G43.
37. Di Leo V, D'Inca R, Barollo M, et al. Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat. Dig Liver Dis 2001;33:135-9.
38. Tran CD, Butler RN, Howarth GS, Philcox JC, Rofe AM, Coyle P. Regional distribution and localization of zinc and metallothionein in the intestine of rats fed diets differing in zinc content. Scand J Gastroenterol 1999;34:689-95.
39. Bruwer M, Schmid KW, Metz KA, Krieglstein CF, Senninger N, Schurmann G. Increased expression of metallothionein in inflammatory bowel disease. Inflamm Res 2001;50:289-93.
40. Haglund U. Gut ischaemia. Gut 1994;35:S73-S6.